SAN FRANCISCO, November 7, 2022 /PRNewswire/ — vial welcomed Robert A HauserMD, MBA, as a new member of the Central Nervous System (CNS) Advisory Board in their Neurology CRO. dr Hauser is Director of the Center for Parkinson’s Disease and Movement Disorders and Professor of Neurology at the University of South Florida.
Vial is a technology-enabled CRO providing next-generation clinical trial management services that enable significantly faster and more efficient trials for biotech sponsors at up to 50% lower costs. the vial Neurology CRO is characterized by the use of digital technologies such as the Vial Technology Platform, which brings together eSource, EDC, eTMFand ePRO, in a connected system to streamline site processes. These world-class CRO services will accelerate the development of new therapies and devices for neurology sponsors and patients.
“We are very pleased, Dr. Hauser as a Scientific Advisor to our Neurology CRO. His contributions and extensive clinical experience in Parkinson’s research will be invaluable to Vial as we continue to develop our products and services across indications,” he said Simon BurnsCEO and co-founder of Vial.
dr Hauser is a specialist in neurology and has gained international recognition for his research into movement disorders. He has received 40 research grants from multiple institutions, including the Michael J. Fox Foundation for Parkinson’s Research and the National Parkinson’s Foundation, and was elected to the Castle…
